ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 754110 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 754110; 2) Community: the network communities that were significantly associated with the response to NSC 754110; 3) Molecule: the relationships between components within communities and NSC 754110; 4) MDR: the compounds that were significantly associated with the NSC 754110.

NSC Compound Enrichment Correlation
NSC 736739 E2GG, 5,7-bis[(4-methoxybenzyl)amino]-3-isopropylpyrazolo[4,3-d]py rimidine 0.000573863872925591 0.42000774
NSC 737147 2-(4-Chloroanilino)-N'-[(4-acetylaminophenyl)sulphonyl]nicotino hydrazide 0.000573863872925591 0.63598776
NSC 755523 Null 0.000573863872925603 0.21015628
NSC 87500 Solacongestidine 0.000573863872925603 0.26539619
NSC 13713 Null 0.000588249147782811 0.37205346
NSC 143241 Dibenzo[de,g]quinoline-6-carboxylic acid, 4,5-dihydro- 1,2,9,10-tetramethoxy-, ethyl ester 0.000649370174092101 0.71109144
NSC 673597 Null 0.000649370174092101 0.42765471
NSC 750050 Null 0.000649370174092101 0.73922922
NSC 752278 2,7-Bis-[2-(2,3,4-trimethoxy-benzylamino)-ethyl]-benzo[lmn][3,8]phenanthroline-1,3,6,8-tetraone di-p-toluensulfonate salt 0.000649370174092101 0.12685402
NSC 753377 3-[2-(1-methyl-1H-indol-3-yl)-1,3-thiazol-4-yl]-1-methyl-1H-pyrrolo[2,3-b]pyridine 0.000649370174092101 0.78065027
Total:96  Current:3    [First] [Prev] [Next] [Last]